Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase.
暂无分享,去创建一个
Debabrata Banerjee | Richard Gorlick | D. Banerjee | J. Bertino | R. Gorlick | Joseph R Bertino | Philipp Mayer-Kuckuk | Gina Capiaux | Tulin Budak-Alpdogan | P. Mayer‐Kuckuk | T. Budak-Alpdogan | G. Capiaux
[1] J. Minna,et al. Unstable methotrexate resistance in human small-cell carcinoma associated with double minute chromosomes. , 1983, The New England journal of medicine.
[2] W. Flintoff,et al. Isolation of a Human cDNA That Complements a Mutant Hamster Cell Defective in Methotrexate Uptake (*) , 1995, The Journal of Biological Chemistry.
[3] S. Asai,et al. Thymidylate Synthase Expression Correlates Closely with E 2 F 1 Expression in Colon Cancer 1 , 2000 .
[4] L. Matherly,et al. Characterization of transport-mediated methotrexate resistance in human tumor cells with antibodies to the membrane carrier for methotrexate and tetrahydrofolate cofactors. , 1992, The Journal of biological chemistry.
[5] H. Lenz,et al. Quantitative analysis of folylpolyglutamate synthetase gene expression in tumor tissues by the polymerase chain reaction: marked variation of expression among leukemia patients. , 1994, Oncology research.
[6] S. Jhanwar,et al. Higher levels of thymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] R. Reddel,et al. Gamma-glutamyl hydrolase conjugase). Purification and properties of the bovine hepatic enzyme. , 1975, The Journal of biological chemistry.
[8] S. Larson,et al. Cells exposed to antifolates show increased cellular levels of proteins fused to dihydrofolate reductase: A method to modulate gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[9] T. T. Wang,et al. Pteroylpolyglutamate hydrolase from human jejunal brush borders. Purification and characterization. , 1986, The Journal of biological chemistry.
[10] A. Admon,et al. Expression cloning of a human cDNA encoding folylpoly(gamma-glutamate) synthetase and determination of its primary structure. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[11] G. Maley,et al. Identification of an RNA binding site for human thymidylate synthase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[12] J. Schornagel,et al. Resistance to methotrexate due to gene amplification in a patient with acute leukemia. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] J. Bertino,et al. Selective treatment of SCID mice bearing methotrexate-transport-resistant human acute lymphoblastic leukemia tumors with trimetrexate and leucovorin protection. , 1995, Blood.
[14] F. Sirotnak,et al. Hydrolytic cleavage of methotrexate gamma-polyglutamates by folylpolyglutamyl hydrolase derived from various tumors and normal tissues of the mouse. , 1986, Cancer research.
[15] J. Bertino,et al. Increase of dihydrofolate reductase activity in cultured mammalian cells after exposure to methotrexate. , 1967, Proceedings of the National Academy of Sciences of the United States of America.
[16] T. T. Wang,et al. Intracellular pteroylpolyglutamate hydrolase from human jejunal mucosa. Isolation and characterization. , 1986, The Journal of biological chemistry.
[17] S. Groshen,et al. High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-fluorouracil. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[18] G. Curt,et al. The pharmacology and clinical use of methotrexate. , 1983, The New England journal of medicine.
[19] L. Loeb,et al. Random Sequence Mutagenesis and Resistance to 5-Fluorouridine in Human Thymidylate Synthases* , 1998, The Journal of Biological Chemistry.
[20] B. Elsenhans,et al. Isolation and characterization of pteroylpolyglutamate hydrolase from rat intestinal mucosa. , 1984, The Journal of biological chemistry.
[21] M. Saier,et al. A major superfamily of transmembrane facilitators that catalyse uniport, symport and antiport. , 1993, Trends in biochemical sciences.
[22] J. Bertino,et al. Karnofsky memorial lecture. Ode to methotrexate. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] D. Banerjee,et al. Role of E2F-1 in chemosensitivity. , 1998, Cancer research.
[24] S. Groshen,et al. Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] S. Mineishi,et al. Post-transplant methotrexate administration leads to improved curability of mice bearing a mammary tumor transplanted with marrow transduced with a mutant human dihydrofolate reductase cDNA. , 1997, Human gene therapy.
[26] W. Flintoff,et al. Isolation of a hamster cDNA clone coding for a function involved in methotrexate uptake. , 1994, The Journal of biological chemistry.
[27] K. Helin,et al. The E2F transcription factors: key regulators of cell proliferation. , 2000, Biochimica et biophysica acta.
[28] Martin R. Johnson,et al. Retroviral transduction of human dihydropyrimidine dehydrogenase cDNA confers resistance to 5-fluorouracil in murine hematopoietic progenitor cells and human CD34+-enriched peripheral blood progenitor cells , 2001, Cancer Gene Therapy.
[29] F. Maley,et al. Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] Ying Wang,et al. Acquisition of Resistance to Antifolates Caused by Enhanced γ-Glutamyl Hydrolase Activity , 1993 .
[31] James T. Lin,et al. Decreased polyglutamylation of methotrexate in acute lymphoblastic leukemia blasts in adults compared to children with this disease. , 1993, Leukemia.
[32] M. Waltham,et al. Translational regulation of the synthesis of dihydrofolate reductase. , 1993, Advances in experimental medicine and biology.
[33] B. Schweitzer,et al. Basis for natural resistance to methotrexate in human acute non-lymphocytic leukemia. , 1991, Leukemia research.
[34] A. Levinson,et al. Isolation and expression of an altered mouse dihydrofolate reductase cDNA. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[35] J. Bertino,et al. Effects of Overexpression of γ-Glutamyl Hydrolase on Methotrexate Metabolism and Resistance , 2001 .
[36] S. Groshen,et al. Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] C. Cordon-Cardo,et al. Levels of E2F-1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylate synthase. , 2000, Cancer research.
[38] S. Groshen,et al. p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survival. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[39] J. Nevins,et al. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. , 1992, Science.
[40] M. Waltham,et al. Acute monocytic leukemia: a myeloid leukemia subset that may be sensitive to methotrexate. , 1995, Leukemia.
[41] S. Mineishi,et al. Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[42] F. Berger,et al. Ligand-mediated Induction of Thymidylate Synthase Occurs by Enzyme Stabilization , 1999, The Journal of Biological Chemistry.
[43] C. Pui,et al. Mutations in the gene for human dihydrofolate reductase: an unlikely cause of clinical relapse in pediatric leukemia after therapy with methotrexate. , 1996, Leukemia.
[44] D. Haber,et al. Properties of an altered dihydrofolate reductase encoded by amplified genes in cultured mouse fibroblasts. , 1981, The Journal of biological chemistry.
[45] L. Matherly,et al. The cellular pharmacology of methotrexate. , 1985, Pharmacology & therapeutics.
[46] P C Elwood,et al. Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[47] P. Steinherz,et al. Defective transport as a mechanism of acquired resistance to methotrexate in patients with acute lymphocytic leukemia. , 1992, Blood.
[48] Thea D. Tlsty,et al. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53 , 1992, Cell.
[49] D. Priest,et al. The role of folylpolyglutamate synthetase and gamma-glutamyl hydrolase in altering cellular folyl- and antifolylpolyglutamates. , 1987, Advances in enzyme regulation.
[50] P. Johnston,et al. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. , 1995, Cancer research.
[51] M. Relling,et al. Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia. , 1994, The Journal of clinical investigation.
[52] Joseph,et al. Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules. , 1992, Cancer research.
[53] A. Klein-Szanto,et al. E2F-1 gene transfer enhances invasiveness of human head and neck carcinoma cell lines. , 2000, Cancer research.
[54] N. Dyson. The regulation of E2F by pRB-family proteins. , 1998, Genes & development.
[55] R. Diasio,et al. Dihydropyrimidine dehydrogenase activity and fluorouracil chemotherapy. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[56] J. McPherson,et al. Expression of a novel double-mutant dihydrofolate reductase-cytidine deaminase fusion gene confers resistance to both methotrexate and cytosine arabinoside. , 1999, Human gene therapy.
[57] R. Schimke,et al. Gene amplification in a leukemic patient treated with methotrexate. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[58] K. Scotto,et al. Phenotypic expression in Escherichia coli and nucleotide sequence of two Chinese hamster lung cell cDNAs encoding different dihydrofolate reductases , 1984, Molecular and Cellular Biology.
[60] S. Mineishi,et al. Gene therapy utilizing drug resistance genes: A review , 1994, Stem cells.
[61] G. Wahl,et al. Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[62] P. Gimotty,et al. Elevated dihydrofolate reductase and impaired methotrexate transport as elements in methotrexate resistance in childhood acute lymphoblastic leukemia. , 1995, Blood.
[63] C. Allegra,et al. Inhibition of phosphoribosylaminoimidazolecarboxamide transformylase by methotrexate and dihydrofolic acid polyglutamates. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[64] E. Ercikan-Abali,et al. Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line. , 1996, Journal of the National Cancer Institute.
[65] K. Cowan,et al. A novel cDNA restores reduced folate carrier activity and methotrexate sensitivity to transport deficient cells. , 1994, The Journal of biological chemistry.
[66] D. Banerjee,et al. Identification and characterization of a mutation in the dihydrofolate reductase gene from the methotrexate-resistant Chinese hamster ovary cell line Pro-3 MtxRIII. , 1990, The Journal of biological chemistry.
[67] J. E. Hyde,et al. The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasites. , 1990, Pharmacology & therapeutics.
[68] J. Nevins,et al. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes , 1995, Molecular and cellular biology.
[69] J. Trent,et al. Cytologic evidence for gene amplification in methotrexate-resistant cells obtained from a patient with ovarian adenocarcinoma. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[70] E. Ercikan-Abali,et al. Isolation and Characterization of Thymitaq (AG337) and 5-Fluoro-2-deoxyuridylate-resistant Mutants of Human Thymidylate Synthase from Ethyl Methanesulfonate-exposed Human Sarcoma HT1080 Cells* , 1998, The Journal of Biological Chemistry.
[71] G. Wahl,et al. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles , 1992, Cell.
[72] F. Berger,et al. Single amino acid substitution defines a naturally occurring genetic variant of human thymidylate synthase. , 1990, Molecular pharmacology.
[73] F. M. Huennekens,et al. THE "INDUCTION" OF DIHYDROFOLIC REDUCTASE ACTIVITY IN LEUKOCYTES AND ERYTHROCYTES OF PATIENTS TREATED WITH AMETHOPTERIN. , 1963, The Journal of clinical investigation.
[74] B. Schweitzer,et al. Dihydrofolate reductase as a therapeutic target , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[75] Joseph,et al. Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gene mutations. , 1995, Blood.
[76] R. Levine,et al. Chemistry and Biology of Pteridines and Folates , 2002, Springer US.
[77] B. Schweitzer,et al. Amplification of a polymorphic dihydrofolate reductase gene expressing an enzyme with decreased binding to methotrexate in a human colon carcinoma cell line, HCT-8R4, resistant to this drug. , 1989, The Journal of biological chemistry.
[78] M. Waltham,et al. Active site-directed double mutants of dihydrofolate reductase. , 1996, Cancer research.
[79] S. Mineishi,et al. Ex vivo expansion and selection of human CD34+ peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer. , 1995, Blood.
[80] D. Rodbard,et al. Enhanced inhibition of thymidylate synthase by methotrexate polyglutamates. , 1985, The Journal of biological chemistry.
[81] M. Relling,et al. Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemia , 1994 .
[82] C. Heidelberger,et al. Biochemical characterization of fluoropyrimidine-resistant murine leukemic cell lines. , 1982, Cancer research.
[83] J. Bertino,et al. Enzymatic synthesis of folylpolyglutamates. Characterization of the reaction and its products. , 1980, The Journal of biological chemistry.
[84] M. Waltham,et al. Dihydrofolate reductase protein inhibits its own translation by binding to dihydrofolate reductase mRNA sequences within the coding region. , 1997, Biochemistry.
[85] R. McIvor,et al. Isolation and characterization of a variant dihydrofolate reductase cDNA from methotrexate-resistant murine L5178Y cells. , 1990, Nucleic acids research.
[86] S. Barni,et al. Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.